Abstract

Implementation in the Polish legal system of the amendment of the Act on Counteracting Drug Addiction on 7 May 2022 allowed for a possibility of cultivating in Poland hemp other than fibrous for the needs of the pharmaceutical industry. The paper discusses the path that has led from the legalization of cannabis and its products to a gradual change of attitude both in international and national legislation. The aim of the study is also to familiarize the reader with the requirements the Polish legislator has placed on entities that intend to grow hemp other than fibrous for the production of pharmaceutical raw material.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.